Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn

The giant freshwater prawn/giant river prawn, Macrobrachium rosenbergii is one of the high market value crustaceans cultured worldwide. The intensified aquaculture of the species has led to the outbreak of infectious diseases, prominently, the white tail disease (WTD). It is caused by the infection...

Full description

Bibliographic Details
Main Authors: Low, Chen Fei, Chong, Chou Min, Loh, Jiun Yan
Format: Article
Language:English
Published: Elsevier 2020
Online Access:http://psasir.upm.edu.my/id/eprint/89007/1/ROSEN.pdf
_version_ 1825936607440535552
author Low, Chen Fei
Chong, Chou Min
Loh, Jiun Yan
author_facet Low, Chen Fei
Chong, Chou Min
Loh, Jiun Yan
author_sort Low, Chen Fei
collection UPM
description The giant freshwater prawn/giant river prawn, Macrobrachium rosenbergii is one of the high market value crustaceans cultured worldwide. The intensified aquaculture of the species has led to the outbreak of infectious diseases, prominently, the white tail disease (WTD). It is caused by the infection of Macrobrachium rosenbergii nodavirus (MrNV), which was classified in the family of Nodaviridae. To-date, there are no effective prophylactic and therapeutic agents available against MrNV infection. Vaccination is known to be the most effective prophylactic agent in disease prevention. However, vaccine development against virus infection in crustaceans is equivocal. The feasibility of vaccination in conferring immune protection in crustaceans against infectious diseases is disputable. The argument lies in the fact that crustaceans do not possess adaptive immunity, which is the main immune component that functions to establish immunological memory upon vaccination. Nevertheless, an increasing number of literatures has been documented, which concerns the development of vaccines against infectious diseases in crustaceans. The current review deliberates different approaches in vaccine development against MrNV, which were documented in the past years. It is noteworthy that the live-attenuated MrNV vaccine has not been experimented by far. Thus, the potential of live-attenuated MrNV vaccine in conferring long-term immune protection through the establishment of innate immune memory is currently being discussed.
first_indexed 2024-03-06T10:46:51Z
format Article
id upm.eprints-89007
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T10:46:51Z
publishDate 2020
publisher Elsevier
record_format dspace
spelling upm.eprints-890072021-09-21T23:29:03Z http://psasir.upm.edu.my/id/eprint/89007/ Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn Low, Chen Fei Chong, Chou Min Loh, Jiun Yan The giant freshwater prawn/giant river prawn, Macrobrachium rosenbergii is one of the high market value crustaceans cultured worldwide. The intensified aquaculture of the species has led to the outbreak of infectious diseases, prominently, the white tail disease (WTD). It is caused by the infection of Macrobrachium rosenbergii nodavirus (MrNV), which was classified in the family of Nodaviridae. To-date, there are no effective prophylactic and therapeutic agents available against MrNV infection. Vaccination is known to be the most effective prophylactic agent in disease prevention. However, vaccine development against virus infection in crustaceans is equivocal. The feasibility of vaccination in conferring immune protection in crustaceans against infectious diseases is disputable. The argument lies in the fact that crustaceans do not possess adaptive immunity, which is the main immune component that functions to establish immunological memory upon vaccination. Nevertheless, an increasing number of literatures has been documented, which concerns the development of vaccines against infectious diseases in crustaceans. The current review deliberates different approaches in vaccine development against MrNV, which were documented in the past years. It is noteworthy that the live-attenuated MrNV vaccine has not been experimented by far. Thus, the potential of live-attenuated MrNV vaccine in conferring long-term immune protection through the establishment of innate immune memory is currently being discussed. Elsevier 2020 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/89007/1/ROSEN.pdf Low, Chen Fei and Chong, Chou Min and Loh, Jiun Yan (2020) Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn. Fish and Shellfish Immunology, 104. 431 - 438. ISSN 1050-4648; ESSN: 1095-9947 https://www.sciencedirect.com/science/article/pii/S1050464820304617 10.1016/j.fsi.2020.06.039
spellingShingle Low, Chen Fei
Chong, Chou Min
Loh, Jiun Yan
Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn
title Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn
title_full Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn
title_fullStr Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn
title_full_unstemmed Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn
title_short Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn
title_sort feasibility of vaccination against macrobrachium rosenbergii nodavirus infection in giant freshwater prawn
url http://psasir.upm.edu.my/id/eprint/89007/1/ROSEN.pdf
work_keys_str_mv AT lowchenfei feasibilityofvaccinationagainstmacrobrachiumrosenbergiinodavirusinfectioningiantfreshwaterprawn
AT chongchoumin feasibilityofvaccinationagainstmacrobrachiumrosenbergiinodavirusinfectioningiantfreshwaterprawn
AT lohjiunyan feasibilityofvaccinationagainstmacrobrachiumrosenbergiinodavirusinfectioningiantfreshwaterprawn